Perioperative Complications after Kasai Hepatoportoenterostomy: Data from the Swiss National Biliary Atresia Registry.


Journal

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
ISSN: 1439-359X
Titre abrégé: Eur J Pediatr Surg
Pays: United States
ID NLM: 9105263

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 27 6 2019
medline: 7 4 2021
entrez: 26 6 2019
Statut: ppublish

Résumé

 Hepatoportoenterostomy (HPE) is the first-line treatment for biliary atresia (BA) patients. This study aims to describe perioperative complications after HPE and to analyze their impact on outcome.  Patients with HPE (Swiss National Biliary Atresia Registry, 1994-2017) were retrospectively analyzed. Perioperative complications were defined as complications occurring up to 30 days after surgery. Surgical complications were defined as directly related to the surgical act; medical complications were defined as any other deviation from the uneventful postoperative course.  Sixty-two patients were included. Median age at HPE was 63 days (18-126). Twenty six patients out of 62 (42%) had ≥ 1 complications: 6/62 (10%) surgical, 24/62 (39%) medical, that is, we observed 7 surgical and 28 medical complications. As for medical complications, cholangitis was the most frequent: 19/28 (68%). Lower gestational age at birth correlated with more overall complications (  HPE is often associated with perioperative medical complications. Lower gestational age at birth was significantly associated with more complications. Perioperative complications had no impact on overall outcome.

Identifiants

pubmed: 31238348
doi: 10.1055/s-0039-1692686
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

364-370

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Ana M Calinescu (AM)

Division of Pediatric Surgery, Hopitaux Universitaires de Geneve, University Center of Pediatric Surgery of Western Switzerland, Geneva, Switzerland.

Jim C H Wilde (JCH)

Division of Pediatric Surgery, Hopitaux Universitaires de Geneve, University Center of Pediatric Surgery of Western Switzerland, Geneva, Switzerland.

Simona Korff (S)

Unit of Pediatric Gastroenterology, Hepatology, and Nutrition, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Valérie A McLin (VA)

Unit of Pediatric Gastroenterology, Hepatology, and Nutrition, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Barbara E Wildhaber (BE)

Division of Pediatric Surgery, Hopitaux Universitaires de Geneve, University Center of Pediatric Surgery of Western Switzerland, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH